Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 143 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML

NCT00702403

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Blast Crisis, +36 more
Locations
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • H Lee Moffitt Cancer Center and Research Institute Phase 2 Consortium Tampa, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Oregon Health and Science University Portland, Oregon, United States
View Trial Details
Completed

Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT01349972

Conditions
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +27 more
Locations
  • Mayo Clinic Scottsdale-Phoenix Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias

NCT00261846

Conditions
Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • HealthONE Presbyterian Denver, Colorado, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 111 locations
View Trial Details

Related conditions